A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber

Clinical trial NCT03709121 · COMPLETED

Trial details

NCT number: NCT03709121
Sponsor: Aldeyra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Conjunctivitis, Allergic

Start date: 2018-10-02
Primary completion: 2019-03-20
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.